台股 » 個股 » 生華科 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

生華科

(6492)
可現股當沖
  • 股價
    44.80
  • 漲跌
    ▲0.80
  • 漲幅
    +1.82%
  • 成交量
    254
  • 產業
    上櫃 生技醫療類股
  • 154人加入追蹤

    立即追蹤

  • 本地時間:13:35(已收盤)

     
生華科 (6492)籌碼相關-群益金鼎-台南 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

群益金鼎-台南 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/02/14145.00445.0544.80-3163-1.83%
2025/02/11343.4000.0043.7531761.70%
2025/02/10143.7500.0043.7511790.56%
2025/02/0600.003844.0244.25-38190-19.95%
2025/02/05143.1500.0043.7511930.52%
2025/01/2200.00142.2042.30-1228-0.44%
2025/01/17742.3100.0042.0073791.85%
2025/01/14142.7500.0042.6013820.26%
2025/01/131042.3000.0042.35103842.60%
2025/01/0900.003144.4943.95-31386-8.02%
2025/01/07342.9000.0042.8033890.77%
2025/01/0600.00643.4043.40-6395-1.52%
2025/01/03542.6800.0042.3054021.24%
2024/12/27544.701045.3844.25-5421-1.19%
2024/12/2600.001644.2344.05-16429-3.73%
2024/12/2300.00143.8042.80-1454-0.22%
2024/12/2000.00343.2042.65-3464-0.65%
2024/12/0400.00445.8045.35-4620-0.65%
2024/11/12147.4000.0047.3517260.14%
2024/11/11148.2000.0048.3517310.14%
2024/10/29151.7000.0052.1017720.13%
2024/10/28654.10355.3352.6037560.40%
2024/10/2500.00354.2054.40-3645-0.46%
2024/10/1700.00552.5050.50-5850-0.59%
2024/10/09249.8500.0049.1521,0590.19%
2024/10/08250.8500.0050.8021,0520.19%
2024/10/07252.1000.0052.1021,0520.19%
2024/10/04352.8000.0052.4031,0520.29%
2024/09/30154.70655.6354.40-51,046-0.48%
2024/09/26252.5000.0051.9021,0230.20%
2024/09/19254.20256.2053.2009950.00%
2024/09/1800.003050.6752.30-30943-3.18%
2024/09/10547.7000.0046.9051,0390.48%
2024/09/0900.00249.2548.20-21,034-0.19%
2024/09/05247.7000.0047.4021,0180.20%
2024/09/04248.6500.0047.8521,0170.20%
2024/08/29249.9000.0050.0029930.20%
2024/08/1600.00249.5050.10-2928-0.22%
2024/08/15549.902348.9649.60-18917-1.96%
2024/08/02154.5000.0053.0018090.12%
2024/07/2900.00155.3056.90-1788-0.13%
2024/07/1900.00362.6058.10-3735-0.41%
2024/07/18363.0000.0062.2036580.46%
2024/07/171057.50558.7458.9055430.92%
2024/07/1600.00156.4057.20-1427-0.23%
2024/07/08444.7800.0044.7043151.27%
2024/07/02145.7000.0045.5013070.33%
2024/06/27048.7500.0047.1002960.00%
2024/06/2000.00247.6047.60-2250-0.80%
2024/06/19244.6000.0047.9522240.89%
2024/06/14341.2500.0041.2531541.95%
2024/05/30141.1000.0041.3511600.62%
2024/05/27141.3000.0041.3511640.61%
2024/05/07041.3000.0041.2501800.00%
2024/04/19241.1500.0040.7021861.07%
2024/04/03243.1500.0043.1021911.04%
2024/03/18342.5500.0042.2531991.51%
2024/03/07342.7500.0043.5533220.93%
2024/03/04343.7500.0043.6033390.88%
2024/03/01044.9500.0044.2503440.00%
2024/02/23244.9500.0044.9523940.51%
2024/02/22245.5500.0045.2523980.50%
2024/02/20345.8300.0045.7034110.73%
生華科新藥再獲孤兒藥資格 上市可獲7年市場獨賣保護期Anue鉅亨-2024/10/25
上櫃「肥貓」董監現形 台嘉碩、大宇資、穩懋、生華科為前四肥Anue鉅亨-2024/04/15
生華科治療新冠、流感等泛病毒感染新藥 將啟動二期臨床Anue鉅亨-2023/11/21
生華科 相關文章
生華科 相關影音